All anyone in the automotive industry seems to be talking about these days is the race to develop autonomous cars and new mobility applications. The announcement last month of a new $1 billion Toyota vehicle research operation in Ann Arbor, MI,... Read more »
San Antonio — A few medtech companies will be pitching their products in a “rapid-fire” pitch competition next week at the Emerging Medical Technology Symposium in San Antonio.
The organizers of the symposium, a group of medtech executives and others involved... Read more »
Summer is around the corner and with it the seasonal hot-and-sticky climate, favored stomping grounds for mosquitoes. This year, health officials have warned Houston and other coastal communities along the Gulf coast that Zika virus-bearing mosquitoes could add a very unpleasant... Read more »
Bind Therapeutics was one of the many biotechs to go public amidst the sector’s recent bull run. But while a number of companies have charged forward since, Bind has stumbled, and today, after a lender forced its hand, the company is... Read more »
The venture capital industry is going through big changes, perhaps nowhere more so than in Boston, its birthplace. Today a new fund is coming out of stealth that speaks to recent trends in startups and VC—and it’s also trying to help... Read more »
As aviation regulators and the drone industry work out rules for the quadcopters and other small unmanned aircraft systems that may someday deliver packages—among scores of other commercial missions—one thing is clear: For the drones to reach the potential their backers... Read more »
Summer is just around the corner, and as rainy April rolls into muggy May, here’s a look at the headlines from the last week in North Carolina tech, biotech, agtech, and cleantech news:
—The North Carolina Biotechnology Center awarded $2.5 million... Read more »
A group of biotech veterans have debuted today a new company, Homology Medicine, with a bold claim that their underlying science is a better version of the gene editing methods, such as CRISPR-Cas9, that have captured the attention of patients, doctors,... Read more »
Last year’s shakeup and mea culpa at San Diego’s Acadia Pharmaceuticals (NASDAQ: ACAD) has paid off. The FDA said late today it has approved Acadia’s pimavanserin (Nuplazid), a treatment for psychosis associated with Parkinson’s disease.
Acadia stumbled badly last year,... Read more »
Another accomplished technology leader will control a Seattle sports franchise, but don’t try taking the Alaskan Way Viaduct to see John Stanton in the Mariners owners’ box at Safeco Field over the next two weeks. This week, we’re reviewing a big... Read more »